Founded in 2017, Zhaoke Ophthalmology is a leading ophthalmic pharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapies that address significant unmet medical needs in China. The company is poised to capture the opportunity of the rapidly growing Chinese ophthalmology market. Zhaoke Ophthalmology has a comprehensive drug portfolio of 25 innovative and generic treatments in its pipeline covering the five major eye diseases across both the front and back of the eye. Through its ambitious growth strategy, including partnering with domestic and international pharmaceutical companies, Zhaoke Ophthalmology’s goal is to become a leader in China.